Longitudinal study of patients with Abdominal Aortic Aneurysm in Barcelona
Observational Prospective Study of Individuals with Abdominal Aortic Aneurysm (AAA) to Monitor AAA Growth and Rupture Risk.
This study is tracking patients with Abdominal Aortic Aneurysm in Barcelona to see how their condition changes over time and what happens to them until they need surgery or experience other serious outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Academic / other |
| Locations | 1 site (Barcelona, Catalonia) |
| Trial ID | NCT06827652 on ClinicalTrials.gov |
What this trial studies
The Triple-A Barcelona Study (TABS) is a prospective longitudinal registry that recruits individuals diagnosed with Abdominal Aortic Aneurysm (AAA) at two hospitals in Barcelona. Participants are enrolled if they have an abdominal aortic diameter greater than 30 mm, with data collected through imaging, clinical assessments, and blood samples. The study aims to gather comprehensive medical histories and follow-up measurements until surgical intervention, rupture, or death occurs. This approach allows for a detailed understanding of AAA progression and patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with an infrarenal abdominal aortic diameter greater than 30 mm.
Not a fit: Patients with Type B dissections, saccular aneurysms, mycotic aneurysms, visceral aneurysms, or thoracic aneurysms may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of AAA progression and improve patient management strategies.
How similar studies have performed: Other studies focusing on AAA have shown success in understanding disease progression, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * clinical diagnosis of abdominal aortic aneurysm * infrarenal abdominal aortic diameter greater than 30 mm Exclusion Criteria: * Type B dissections that progress to AAA * saccular aneurysms * mycotic aneurysms * visceral aneurysms * thoracic aneurysms.
Where this trial is running
Barcelona, Catalonia
- Hospital de la Santa Creu i Sant Pau — Barcelona, Catalonia, Spain (Recruiting)
Study contacts
- Principal investigator: Maria Sabater-Lleal, PhD — Research Institute/hosp/santa Creu/pau
- Study coordinator: Maria Sabater-Lleal, PhD
- Email: msabater@santpau.cat
- Phone: +34932919000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.